Advanced Technologies for Novel Therapeutics

Home  Advanced Technologies for Novel Therapeutics

  • LifeSciences
211 Warren Street
Newark, NJ 07102
(201) 693-8973
  • About

    ATNT is the first biotech company which develops novel cross-disciplinary engineering methods, to find the most effective molecular targets for treatment of complex human disorders. Every year billions of dollars are spent in pharmaceutical and biotech companies, to discover novel therapeutic targets.

    Array
    (
        [0] => Alissa Cadigan - RSM US
        [1] => Ashley Sarohkian - Capital One
        [2] => Badri Nittoor - eureQa
        [3] => Benjamin	Novak - Morgan Lewis
        [4] => Bin Guan - Yorktel
        [5] => Blake Goodman - JLL
        [6] => Bret Morgan - CoWerking
        [7] => Chris DeMayo - Withum
        [8] => Christina Giglio - Robert Half
        [9] => David Powell - Mission50
        [10] => George Abraham - Rhodium Strategies
        [11] => Hitesh Ramani - Deloitte
        [12] => Jennifer Core - BDO
        [13] => Joshua Goldberg - Nathlaw
        [14] => Kelly Ford - Edison Partners
        [15] => Kevin Askew - TechXtend
        [16] => Kevin Richards - Princeton Identity
        [17] => Marc McCabe - Crystal & Company
        [18] => Matt DeJesus - ViaWest
        [19] => Michael Crafton - Alvarez & Marsal
        [20] => Michael Dietze - TierPoint
        [21] => Michael Galkin - VoiceNext
        [22] => Michelle Capezza - Epstein Becker & Green
        [23] => Mike Funk - Alliant Tech
        [24] => Mike Profit - WorkWave
        [25] => Parag Pruthi - Niksun
        [26] => Phil Kennard - Futurestay
        [27] => Phil Romero - Grant Thornton
        [28] => Richard Cleaveland - Eisner Amper
        [29] => Ryan Sydorko - EY
        [30] => Scott Cowan - DLA Piper
        [31] => Tim Dluoik - KPMG
        [32] => Timur Pakay - FDU
        [33] => Vijay Ajuwalia - Edward Jones
    )